Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Preclinical CRO Market by Type (Bioanalysis and DMPK Studies, Toxicology Testing, Others), By Application (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028-report

Global Preclinical CRO Market by Type (Bioanalysis and DMPK Studies, Toxicology Testing, Others), By Application (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Report ID: 136831 3300 Pharma & Healthcare 377 232 Pages
                                          

Industry Growth Insights published a new data on “Preclinical CRO Market”. The research report is titled “Preclinical CRO Market research by Types (Bioanalysis and DMPK Studies, Toxicology Testing, Others), By Applications (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies), By Players/Companies Charles River Laboratories, Laboratory Corporation of America, Envigo, Eurofins Scientific, PRA Health Science, Wuxi AppTec, Medpace, Pharmaceutical Product Development, Paraxel”. As per the latest research Preclinical CRO market is expected to expand at a CAGR of xx% in the forecast period.

Scope Of The Report

Report Attributes

Report Details

Report Title

Preclinical CRO Market Research Report

By Type

Bioanalysis and DMPK Studies, Toxicology Testing, Others

By Application

Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies

By Companies

Charles River Laboratories, Laboratory Corporation of America, Envigo, Eurofins Scientific, PRA Health Science, Wuxi AppTec, Medpace, Pharmaceutical Product Development, Paraxel

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2020

Historical Year

2018 to 2019 (Data from 2010 can be provided as per availability)

Forecast Year

2028

Number of Pages

232

Number of Tables & Figures

163

Customization Available

Yes, the report can be customized as per your need.


Global Preclinical CRO Industry Outlook

Global Preclinical CRO Market Report Segments:

The global Preclinical CRO market is segmented on the basis of:

Types

Bioanalysis and DMPK Studies, Toxicology Testing, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Charles River Laboratories
  2. Laboratory Corporation of America
  3. Envigo
  4. Eurofins Scientific
  5. PRA Health Science
  6. Wuxi AppTec
  7. Medpace
  8. Pharmaceutical Product Development
  9. Paraxel

Global Preclinical CRO Market Overview

Highlights of The Preclinical CRO Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

    1. Bioanalysis and DMPK Studies
    2. Toxicology Testing
    3. Others
  1. By Application:

    1. Biopharmaceutical Companies
    2. Government and Academic Institutes
    3. Medical Device Companies
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Preclinical CRO Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Preclinical CRO Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1 Executive Summary

2 Assumptions and Acronyms Used

3 Research Methodology

4 Preclinical CRO Industry Overview
    4.1 Introduction
        4.1.1 Market Taxonomy
        4.1.2 Market Definition
    4.2 Macro-Economic Factors
        4.2.1 Industry Outlook
    4.3 Preclinical CRO Industry Dynamics
        4.3.1 Market Drivers
        4.3.2 Market Restraints
        4.3.3 Opportunity
        4.3.4 Market Trends
    4.4 Preclinical CRO Industry - Supply Chain
    4.5 Global Preclinical CRO Industry Forecast
        4.5.1 Preclinical CRO Industry Size (US$ Mn) and Y-o-Y Growth
        4.5.2 Preclinical CRO Industry Absolute $ Opportunity

5 Global Preclinical CRO Industry Analysis and Forecast by Services
    5.1 Market Trends
    5.2 Introduction
        5.2.1 Basis Point Share (BPS) Analysis by Services
        5.2.2 Y-o-Y Growth Projections by Services
    5.3 Preclinical CRO Industry Size Forecast by Services
        5.3.1 Bioanalysis and DMPK Studies
        5.3.2 Toxicology Testing (Kindly Refer Page No. 13 -14)
        5.3.3 Others
    5.4 Absolute $ Opportunity Assessment by Services
    5.5 Market Attractiveness/Growth Potential Analysis by Services

6 Global Preclinical CRO Industry Analysis and Forecast by End-user
    6.1 Market Trends
    6.2 Introduction
        6.2.1 Basis Point Share (BPS) Analysis by End-user
        6.2.2 Y-o-Y Growth Projections by End-user
    6.3 Preclinical CRO Industry Size Forecast by End-user
        6.3.1 Biopharmaceutical Companies
        6.3.2 Government and Academic Institutes
        6.3.3 Medical Device Companies
    6.4 Absolute $ Opportunity Assessment by End-user
    6.5 Market Attractiveness/Growth Potential Analysis by End-user

7 Global Preclinical CRO Industry Analysis and Forecast by Region
    7.1 Market Trends
    7.2 Introduction
        7.2.1 Basis Point Share (BPS) Analysis by Region
        7.2.2 Y-o-Y Growth Projections by Region
    7.3 Preclinical CRO Industry Size Forecast by Region
        7.3.1 North America
        7.3.2 Europe
        7.3.3 Asia Pacific
        7.3.4 Latin America
        7.3.5 Middle East and Africa (MEA)
    7.4 Absolute $ Opportunity Assessment by Region
    7.5 Market Attractiveness/Growth Potential Analysis by Region

8 Coronavirus Disease (COVID-19) Impact
    8.1 Introduction
    8.2 Market Trends
    8.3 Patient Data
    8.4 Current Impact Analysis
    8.5 Future Impact Analysis
    8.6 Economic Impact Analysis
    8.7 Government Policies
    8.8 Investment Scenario

9 North America Preclinical CRO Industry Analysis and Forecast
    9.1 Introduction
        9.1.1 Basis Point Share (BPS) Analysis by Country
        9.1.2 Y-o-Y Growth Projections by Country
    9.2 North America Preclinical CRO Industry Size Forecast by Country
        9.2.1 U.S.
        9.2.2 Canada
    9.3 Absolute $ Opportunity Assessment by Country
    9.4 North America Preclinical CRO Industry Size Forecast by Services
        9.4.1 Bioanalysis and DMPK Studies
        9.4.2 Toxicology Testing
        9.4.3 Others
    9.5 Basis Point Share (BPS) Analysis by Services
    9.6 Y-o-Y Growth Projections by Services
    9.7 North America Preclinical CRO Industry Size Forecast by End-user
        9.7.1 Biopharmaceutical Companies
        9.7.2 Government and Academic Institutes
        9.7.3 Medical Device Companies
    9.8 Basis Point Share (BPS) Analysis by End-user
    9.9 Y-o-Y Growth Projections by End-user
    9.10 Market Attractiveness/Growth Potential Analysis
        9.10.1 By Country
        9.10.2 By Services
        9.10.3 By End-user

10 Europe Preclinical CRO Industry Analysis and Forecast
    10.1 Introduction
        10.1.1 Basis Point Share (BPS) Analysis by Country
        10.1.2 Y-o-Y Growth Projections by Country
    10.2 Europe Preclinical CRO Industry Size Forecast by Country
        10.2.1 Germany
        10.2.2 France
        10.2.3 Italy
        10.2.4 U.K.
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Absolute $ Opportunity Assessment by Country
    10.4 Europe Preclinical CRO Industry Size Forecast by Services
        10.4.1 Bioanalysis and DMPK Studies
        10.4.2 Toxicology Testing
        10.4.3 Others
    10.5 Basis Point Share (BPS) Analysis by Services
    10.6 Y-o-Y Growth Projections by Services
    10.7 Europe Preclinical CRO Industry Size Forecast by End-user
        10.7.1 Biopharmaceutical Companies
        10.7.2 Government and Academic Institutes
        10.7.3 Medical Device Companies
    10.8 Basis Point Share (BPS) Analysis by End-user
    10.9 Y-o-Y Growth Projections by End-user
    10.10 Market Attractiveness/Growth Potential Analysis
        10.10.1 By Country
        10.10.2 By Services
        10.10.3 By End-user

11 Asia Pacific Preclinical CRO Industry Analysis and Forecast
    11.1 Introduction
        11.1.1 Basis Point Share (BPS) Analysis by Country
        11.1.2 Y-o-Y Growth Projections by Country
    11.2 Asia Pacific Preclinical CRO Industry Size Forecast by Country
        11.2.1 China
        11.2.2 Japan
        11.2.3 South Korea
        11.2.4 India
        11.2.5 Australia
        11.2.6 Rest of Asia Pacific (APAC)
    11.3 Absolute $ Opportunity Assessment by Country
    11.4 Asia Pacific Preclinical CRO Industry Size Forecast by Services
        11.4.1 Bioanalysis and DMPK Studies
        11.4.2 Toxicology Testing
        11.4.3 Others
    11.5 Basis Point Share (BPS) Analysis by Services
    11.6 Y-o-Y Growth Projections by Services
    11.7 Asia Pacific Preclinical CRO Industry Size Forecast by End-user
        11.7.1 Biopharmaceutical Companies
        11.7.2 Government and Academic Institutes
        11.7.3 Medical Device Companies
    11.8 Basis Point Share (BPS) Analysis by End-user
    11.9 Y-o-Y Growth Projections by End-user
    11.10 Market Attractiveness/Growth Potential Analysis
        11.10.1 By Country
        11.10.2 By Services
        11.10.3 By End-user

12 Latin America Preclinical CRO Industry Analysis and Forecast
    12.1 Introduction
        12.1.1 Basis Point Share (BPS) Analysis by Country
        12.1.2 Y-o-Y Growth Projections by Country
    12.2 Latin America Preclinical CRO Industry Size Forecast by Country
        12.2.1 Brazil
        12.2.2 Mexico
        12.2.3 Rest of Latin America
    12.3 Absolute $ Opportunity Assessment by Country
    12.4 Latin America Preclinical CRO Industry Size Forecast by Services
        12.4.1 Bioanalysis and DMPK Studies
        12.4.2 Toxicology Testing
        12.4.3 Others
    12.5 Basis Point Share (BPS) Analysis by Services
    12.6 Y-o-Y Growth Projections by Services
    12.7 Latin America Preclinical CRO Industry Size Forecast by End-user
        12.7.1 Biopharmaceutical Companies
        12.7.2 Government and Academic Institutes
        12.7.3 Medical Device Companies
    12.8 Basis Point Share (BPS) Analysis by End-user
    12.9 Y-o-Y Growth Projections by End-user
    12.10 Market Attractiveness/Growth Potential Analysis
        12.10.1 By Country
        12.10.2 By Services
        12.10.3 By End-user

13 Middle East & Africa Preclinical CRO Industry Analysis and Forecast
    13.1 Introduction
        13.1.1 Basis Point Share (BPS) Analysis by Country
        13.1.2 Y-o-Y Growth Projections by Country
    13.2 MEA Preclinical CRO Industry Size Forecast by Country
        13.2.1 Saudi Arabia
        13.2.2 South Africa
        13.2.3 UAE
        13.2.4 Rest of MEA
    13.3 Absolute $ Opportunity Assessment by Country
    13.4 MEA Preclinical CRO Industry Size Forecast by Services
        13.4.1 Bioanalysis and DMPK Studies
        13.4.2 Toxicology Testing
        13.4.3 Others
    13.5 Basis Point Share (BPS) Analysis by Services
    13.6 Y-o-Y Growth Projections by Services
    13.7 MEA Preclinical CRO Industry Size Forecast by End-user
        13.7.1 Biopharmaceutical Companies
        13.7.2 Government and Academic Institutes
        13.7.3 Medical Device Companies
    13.8 Basis Point Share (BPS) Analysis by End-user
    13.9 Y-o-Y Growth Projections by End-user
    13.10 Market Attractiveness/Growth Potential Analysis
        13.10.1 By Country
        13.10.2 By Services
        13.10.3 By End-user

14 Competition Landscape
    14.1 Global Preclinical CRO Industry: Market Share Analysis
    14.2 Preclinical CRO Distributors and Customers
    14.3 Preclinical CRO Industry: Competitive Dashboard
    14.4 Company Profiles (Details – Overview, Financials, Developments, Strategy)
        14.4.1 Envigo Corporation
        14.4.2 Eurofins Scientific
        14.4.3 ICON Plc.
        14.4.4 Laboratory Corporation of America, Inc.
        14.4.5 Medpace, Inc.
        14.4.6 MPI research
        14.4.7 PARAXEL International Corporation
        14.4.8 Pharmaceutical Product Development (PPD), LLC
        14.4.9 PRA Health Sciences, Inc
        14.4.10 Wuxi AppTec

Our Trusted Clients

Contact Us